EPRXEupraxia Pharmaceuticals Inc.
9.370CAD-3.60%Mkt Cap: 466.53M $P/E:

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug de…

Key Statistics

Company
Market Cap466.53M $
Enterprise Value371.67M $
Revenue (TTM)
Gross Profit
Net Income (TTM)-28.09M $
Revenue/Share
Last Price9.370 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees49
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-6.60
PEG
EV/EBITDA-8.97
EV/Revenue
P/S
P/B6.64
EPS (TTM)-1.42
EPS (Forward)-1.45
52W Range
6.94041% of range12.86
52W High12.86 CAD
52W Low6.940 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-47.02%
ROA-44.78%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-20.79M $
CapEx (TTM)428.91K $
FCF Margin
FCF Yield-2.95%
Net Debt-96.00M $
Net Debt/EBITDA2.32
Balance Sheet
Debt/Equity0.00
Current Ratio16.00
Quick Ratio15.71
Book Value/Sh1.403 CAD
Cash/Share2.028 CAD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 CAD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)16.00 CAD
Upside (mean)+70.8%
Target Range14.00 CAD18.00 CAD
CAD14.00+70.8% to meanCAD18.00
# Analysts2
Ownership
Shares Out.65.91M
Float55.69M
Insiders14.22%
Institutions45.02%
Short Interest
Short Ratio1.4d
Short % Float0.17%
Short % Out.0.14%
Shares Short88.44K
Short (prev mo.)67.03K
Technical
SMA 509.101 (+3.0%)
SMA 2009.826 (-4.6%)
Beta1.50
S&P 52W Chg18.16%
Avg Vol (30d)58.74K
Avg Vol (10d)54.27K
Technical Indicators
RSI (14)59.0
MACD0.0951
MACD Signal0.0238
MACD Hist.+0.0713
BB Upper9.787 CAD
BB Middle9.044 CAD
BB Lower8.302 CAD
BB Width16.41%
ATR (14)0.4698 CAD
Vol Ratio (20d)2.84x